R
Redx Pharma PLC
LSE:REDX
Redx Pharma PLC
LSE:REDX
Price:
15 GBX
31.58%
Market Closed
Updated:
May 8, 2024
Redx Pharma PLC
Cash from Operating Activities
|
Redx Pharma PLC
Cash from Operating Activities Peer Comparison
Comparables:
GSK
AZN
INDV
HIK
DPH
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
R
|
Redx Pharma PLC
LSE:REDX
|
Cash from Operating Activities
-£34.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Cash from Operating Activities
£7.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Cash from Operating Activities
$9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
33%
|
CAGR 10-Years
4%
|
|
|
Indivior PLC
LSE:INDV
|
Cash from Operating Activities
-$334m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Cash from Operating Activities
$608m
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Cash from Operating Activities
£63.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
0%
|
CAGR 10-Years
6%
|
See Also
What is Redx Pharma PLC's Cash from Operating Activities?
Cash from Operating Activities
-34.7m
GBP
-34.7m
GBP
Based on the financial report for Sep 30, 2023, Redx Pharma PLC's Cash from Operating Activities amounts to -34.7m GBP.
What is Redx Pharma PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-15%
-15%
Over the last year, the Cash from Operating Activities growth was -310%.
You don't have any saved screeners yet
